BDPT

BioAdaptives, Inc.

Price Chart

Latest Quote

$0.01

-0.00 (-5.00%)

Current Price

Previous Close	$0.01
Open	$0.01
Day High	$0.01
Day Low	$0.01
Volume	329,280

Fetched: 2026-06-05T03:01:36

Stock Information

Shares Outstanding	12.01M
Sector	Consumer Defensive
Industry	Packaged Foods
Market Cap	$68K
EPS (TTM)	$-0.14
Exchange	OID

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Book/sh	$-0.18
Employees	1

Financial Ratios

Returns & Margins

Ownership

Insider Ownership	0.15%
Insider & Institutional transactions data not available

Valuation Ratios

P/B

-0.03

Analyst Data

Recommendation

none

Technical Indicators

SMA20	$0.01
SMA50	$0.01
SMA200	$0.02
ATR	0.0006

Rel Volume

2.68

Performance History

Week	-48.18%
Month	-40.00%
Quarter	-62.00%
6 Months	-76.54%
YTD	-74.09%
Year	-91.86%
3 Years	-93.67%
5 Years	-99.87%
10 Years	-99.98%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-04	$0.01	329,280
2026-06-03	$0.01	1,780,261
2026-06-02	$0.01	185,800
2026-06-01	$0.01	0
2026-05-29	$0.01	85,132
2026-05-28	$0.01	0
2026-05-27	$0.01	0
2026-05-26	$0.01	0
2026-05-22	$0.01	0
2026-05-21	$0.01	61,200
2026-05-20	$0.01	0
2026-05-19	$0.01	5,170
2026-05-18	$0.01	0
2026-05-15	$0.01	0
2026-05-14	$0.01	0
2026-05-13	$0.01	0
2026-05-12	$0.01	0
2026-05-11	$0.01	0
2026-05-08	$0.01	0
2026-05-07	$0.01	6,035
2026-05-06	$0.01	20,001
2026-05-05	$0.01	2,693

About BioAdaptives, Inc.

BioAdaptives, Inc. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers MyndMed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health; Zeranovia, a weight loss enhancer; Wynovia to help reduce the loss of lean muscle mass during dieting; and Xcellara, a regenerative wellness solution. It also provides canine products under the PawPa brand; dog chew products under the Regen brand; and Lung Flute, a medical device. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.

📰 Latest News

No news articles available at the moment. Check back later for updates on BDPT.

Period:

Income Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue
Reconciled Cost Of Revenue	$26,639	$17,746	$10,050	$9,671
Cost Of Revenue	$8,639	$17,746	$10,050	$9,671
Total Revenue	$12,669	$28,565	$17,176	$19,776
Operating Revenue	$12,669	$28,565	$17,176	$19,776
Expenses
Interest Expense	$91,978	$162,891	$289,121	$272,394
Total Expenses	$533,409	$257,486	$439,076	$655,857
Other Income Expense	$-286,443	$-320,654	$-184,549	$-141,473
Other Non Operating Income Expenses	$4,950	-	-	-
Net Non Operating Interest Income Expense	$-91,978	$-162,891	$-289,121	$-272,394
Interest Expense Non Operating	$91,978	$162,891	$289,121	$272,394
Operating Expense	$524,770	$239,740	$429,026	$646,186
General And Administrative Expense	$504,829	$211,566	$366,878	$512,395
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-899,161	$-712,466	$-895,570	$-1,049,948
Net Interest Income	$-91,978	$-162,891	$-289,121	$-272,394
Normalized Income	$-607,768	$-391,812	$-711,021	$-908,475
Net Income From Continuing And Discontinued Operation	$-899,161	$-712,466	$-895,570	$-1,049,948
Total Operating Income As Reported	$-602,090	$-228,921	$-421,900	-
Net Income Common Stockholders	$-899,161	$-712,466	$-895,570	$-1,049,948
Net Income	$-899,161	$-712,466	$-895,570	$-1,049,948
Net Income Including Noncontrolling Interests	$-904,761	$-712,466	$-895,570	$-1,049,948
Net Income Continuous Operations	$-904,761	$-712,466	$-895,570	$-1,049,948
Pretax Income	$-904,761	$-712,466	$-895,570	$-1,049,948
Special Income Charges	$-81,350	$-13,200	$0	$-51,000
Operating Income	$-520,740	$-228,921	$-421,900	$-636,081
Depreciation Amortization Depletion Income Statement	$19,941	$28,174	$62,148	$133,791
Depreciation And Amortization In Income Statement	$19,941	$28,174	$62,148	$133,791
Amortization Of Intangibles Income Statement	$19,941	$28,174	$62,148	$133,791
Gross Profit	$4,030	$10,819	$7,126	$10,105
Per Share
Diluted EPS	$-0.06	$-0.06	$-1.50	$-4.50
Basic EPS	$-0.06	$-0.06	$-1.50	$-4.50
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-501,449	$-200,747	$-359,752	$-502,290
Total Unusual Items	$-291,393	$-320,654	$-184,549	$-141,473
Total Unusual Items Excluding Goodwill	$-291,393	$-320,654	$-184,549	$-141,473
Reconciled Depreciation	$1,941	$28,174	$62,148	$133,791
EBITDA (Bullshit earnings)	$-792,842	$-521,401	$-544,301	$-643,763
EBIT	$-812,783	$-549,575	$-606,449	$-777,554
Diluted Average Shares	$16,430,852	$11,943,456	$706,742	$224,952
Basic Average Shares	$16,430,852	$11,943,456	$706,742	$224,952
Diluted NI Availto Com Stockholders	$-899,161	$-712,466	$-895,570	$-1,049,948
Write Off	$81,350	$0	-	-
Gain On Sale Of Security	$-210,043	$-307,454	$-184,549	$-90,473
Amortization	$19,941	$28,174	$62,148	$133,791
Selling General And Administration	$504,829	$211,566	$366,878	$512,395
Other Gand A	$504,829	$211,566	$366,878	$348,495
Other Special Charges	-	$13,200	-	$51,000
Salaries And Wages	-	-	$0	$163,900

Fetched: 2026-02-02

Balance Sheet (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Net Tangible Assets	$-1,463,918	$-1,662,072	$-1,454,491	$-1,152,748
Total Assets	$261,885	$103,998	$37,314	$148,585
Total Non Current Assets	$0	$15,441	$2,990	$59,709
Goodwill And Other Intangible Assets	$0	$15,441	$2,990	$59,709
Current Assets	$261,885	$88,557	$34,324	$88,876
Prepaid Assets	$102,500	$12,500	$0	$1,000
Inventory	$19,115	$15,281	$8,877	$4,750
Receivables	$2,800	$0	-	-
Other Receivables	$2,800	-	-	-
Cash Cash Equivalents And Short Term Investments	$137,470	$60,776	$25,447	$83,126
Cash And Cash Equivalents	$137,470	$60,776	$25,405	$82,936
Cash Financial	$137,470	$60,776	$25,405	$82,936
Other Intangible Assets	-	$15,441	$2,990	$59,709
Cash Equivalents	-	$60,776	-	-
Debt
Net Debt	$205,626	$268,402	$366,634	$353,896
Total Debt	$343,096	$329,178	$392,039	$436,832
Current Debt And Capital Lease Obligation	$343,096	$329,178	$392,039	$436,832
Current Debt	$343,096	$329,178	$392,039	$436,832
Other Current Borrowings	$311,000	$321,658	$381,793	$403,117
Liabilities
Total Liabilities Net Minority Interest	$1,725,803	$1,750,629	$1,488,815	$1,241,624
Total Non Current Liabilities Net Minority Interest	$0	$0	$0	$0
Current Liabilities	$1,725,803	$1,750,629	$1,488,815	$1,241,624
Other Current Liabilities	$1,053,249	$977,872	$686,856	$557,042
Current Notes Payable	$32,096	$7,520	$10,246	$33,715
Payables And Accrued Expenses	$329,458	$443,579	$409,920	$247,750
Interest Payable	$172,438	$139,277	$101,966	$68,341
Payables	$155,999	$3,283	$6,939	$1,750
Other Payable	$150,000	-	-	-
Accounts Payable	$5,999	$3,283	$6,939	$1,750
Equity
Common Stock Equity	$-1,464,027	$-1,646,633	$-1,451,661	$-1,093,199
Preferred Stock Equity	$109	$2	$160	$160
Total Equity Gross Minority Interest	$-1,463,918	$-1,646,631	$-1,451,501	$-1,093,039
Stockholders Equity	$-1,463,918	$-1,646,631	$-1,451,501	$-1,093,039
Other Equity Interest	$-5,885	-	-	-
Retained Earnings	$-9,163,306	$-8,264,145	$-7,551,679	$-6,656,109
Other
Ordinary Shares Number	$8,215,426	$5,971,734	$1,683,698	$338,731
Share Issued	$8,215,426	$5,971,734	$1,683,698	$338,731
Tangible Book Value	$-1,464,027	$-1,662,074	$-1,454,651	$-1,152,908
Invested Capital	$-1,120,931	$-1,317,455	$-1,059,622	$-656,367
Working Capital	$-1,463,918	$-1,662,072	$-1,454,491	$-1,152,748
Total Capitalization	$-1,463,918	$-1,646,631	$-1,451,501	$-1,093,039
Additional Paid In Capital	$7,704,343	$6,616,915	$6,074,763	$5,557,828
Capital Stock	$930	$599	$25,415	$5,242
Common Stock	$821	$597	$25,255	$5,082
Preferred Stock	$109	$2	$160	$160
Current Accrued Expenses	$173,459	$440,296	$402,981	$246,000
Finished Goods	$19,115	$15,281	-	-
Other Short Term Investments	-	$0	$42	$190

Fetched: 2026-02-02

Cash Flow Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow
Free Cash Flow	$-249,517	$-223,773	$-227,259	$-158,651
Operating Activities
Operating Cash Flow	$-249,517	$-223,773	$-227,259	$-158,651
Cash Flow From Continuing Operating Activities	$-249,517	$-223,773	$-227,259	$-158,651
Operating Gains Losses	$210,043	$320,612	$184,401	$141,219
Financing Activities
Issuance Of Capital Stock	$294,115	$178,100	$0	-
Financing Cash Flow	$326,211	$259,144	$169,728	$237,000
Cash Flow From Continuing Financing Activities	$326,211	$259,144	$169,728	$237,000
Net Preferred Stock Issuance	$294,115	$0	-	-
Preferred Stock Issuance	$294,115	$0	-	-
Net Common Stock Issuance	$0	$178,100	$0	-
Common Stock Issuance	$0	$178,100	$0	-
Net Other Financing Charges	-	$1,044	-	-
Other
Issuance Of Debt	$32,096	$80,000	$195,000	$257,000
Interest Paid Supplemental Data	$0	$0	$4,728	$16,424
Income Tax Paid Supplemental Data	$0	$0	$0	$0
End Cash Position	$137,470	$60,776	$25,405	$82,936
Beginning Cash Position	$60,776	$25,405	$82,936	$4,587
Changes In Cash	$76,694	$35,371	$-57,531	$78,349
Net Issuance Payments Of Debt	$32,096	$80,000	$169,728	$237,000
Net Short Term Debt Issuance	$32,096	$80,000	$169,728	$0
Short Term Debt Issuance	$32,096	$80,000	$195,000	$0
Change In Working Capital	$76,847	$20,310	$182,428	$235,202
Change In Payables And Accrued Expense	$44,831	$39,214	$185,555	$227,137
Change In Payable	$44,831	$39,214	$185,555	$227,137
Change In Account Payable	$44,831	$39,684	$183,752	$227,137
Change In Prepaid Assets	$57,200	$-12,500	$1,000	$-1,000
Change In Inventory	$-25,184	$-6,404	$-4,127	$9,065
Other Non Cash Items	$261,463	$119,555	$239,186	$216,931
Unrealized Gain Loss On Investment Securities	$0	$42	$148	$254
Asset Impairment Charge	$99,350	$0	-	-
Depreciation Amortization Depletion	$1,941	$28,174	$62,148	$133,791
Depreciation And Amortization	$1,941	$28,174	$62,148	$133,791
Amortization Cash Flow	$1,941	$28,174	$62,148	$133,791
Amortization Of Intangibles	$1,941	$28,174	$62,148	$133,791
Gain Loss On Investment Securities	$210,043	$307,412	$184,401	$90,219
Net Income From Continuing Operations	$-899,161	$-712,466	$-895,570	$-1,049,948
Repayment Of Debt	-	$0	$-25,272	$-20,000
Short Term Debt Payments	-	$0	$-25,272	$-20,000
Net Long Term Debt Issuance	-	-	$169,728	$237,000
Long Term Debt Payments	-	-	$-25,272	$-20,000
Long Term Debt Issuance	-	-	$195,000	$257,000
Stock Based Compensation	-	-	$0	$163,900

Fetched: 2026-02-02